NeuPath Q1 2023 Investor Presentation

NeuPath's Q1 2023 investor presentation covers the company's financial performance and outlook across its chronic pain, sports medicine, concussion, and workplace health services markets. The presentation includes forward-looking statements, non-IFRS financial measures, and market data for investor analysis.